Anthropometry and the risk of epithelial ovarian cancer

被引:30
|
作者
Greer, JB [1 ]
Modugno, F [1 ]
Ness, RB [1 ]
Allen, GO [1 ]
机构
[1] Univ Pittsburgh, Dept Epidemiol, Grad Sch Publ Hlth, Pittsburgh, PA 15261 USA
关键词
body mass index; menopause; obesity; ovarian neoplasms; parity; hormones;
D O I
10.1002/cncr.21830
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
BACKGROUND. The association between anthropometric factors and ovarian cancer risk was investigated using data from 762 cases and 1348 controls participating in a population-based case-control Study in the Delaware Valley from 1994-1998. Because factors such as oral contraceptive (OC), hormone therapy (HT), and parity may affect weight and hormone levels, the associations were examined in women with and without these characteristics. METHODS. Unconditional logistic regression was used to calculate odds ratios and 95% confidence intervals while controlling for age, race, parity, family history of ovarian cancer, tubal ligation, and OC use. RESULTS. Compared with controls, cases were taller and heavier in recent years and at age 18. Results did not differ by OC or HT use. However, anthropometric associations differed significantly based oil parity, as increasing anthropometric measures were associated with increased ovarian cancer risk among nulliparous women only. Adjusted OR for recent body mass index (BMI) quartile 4 compared with quartile 1 for nulliparous women was 2.53 (95% confidence interval [CI]: 1.39, 4.61) compared with 0.96 (95% CI: 0.70, 1.31) for parous women. Additionally, adult weight gain was significant only for nulliparous women. Adjusted OR for weight change (recent to age 18) quartile 4 compared with quartile 1 for nulliparous women was 3.73 (95% CI: 1.88, 7.42) versus 1.09 (95% CI: 0.78, 1.51) for parous women. CONCLUSIONS. BMI and weight in women's adult lifetime may be positively associated with ovarian cancer risk. Observations were most apparent for nulliparous women, possibly reflecting all interaction between local inflammation caused by incessant ovulation and increased estrogen exposure on ovarian epithelium.
引用
收藏
页码:2247 / 2257
页数:11
相关论文
共 50 条
  • [31] Hormone replacement therapy and risk of epithelial ovarian cancer
    Purdie, DM
    Bain, CJ
    Siskind, V
    Russell, P
    Hacker, NF
    Ward, BG
    Quinn, MA
    Green, AC
    BRITISH JOURNAL OF CANCER, 1999, 81 (03) : 559 - 563
  • [32] MENSTRUAL FACTORS AND THE RISK OF EPITHELIAL OVARIAN-CANCER
    PARAZZINI, F
    LAVECCHIA, C
    NEGRI, E
    GENTILE, A
    JOURNAL OF CLINICAL EPIDEMIOLOGY, 1989, 42 (05) : 443 - 448
  • [33] Intake of specific carotenoids and the risk of epithelial ovarian cancer
    Zhang, Min
    D'Arcy, C.
    Holman, J.
    Binns, Colin W.
    BRITISH JOURNAL OF NUTRITION, 2007, 98 (01) : 187 - 193
  • [34] Circulating prolactin levels and risk of epithelial ovarian cancer
    Clendenen, Tess V.
    Arslan, Alan A.
    Lokshin, Anna E.
    Liu, Mengling
    Lundin, Eva
    Koenig, Karen L.
    Berrino, Franco
    Hallmans, Goran
    Idahl, Annika
    Krogh, Vittorio
    Lukanova, Annekatrin
    Marrangoni, Adele
    Muti, Paola
    Nolen, Brian M.
    Ohlson, Nina
    Shore, Roy E.
    Sieri, Sabina
    Zeleniuch-Jacquotte, Anne
    CANCER CAUSES & CONTROL, 2013, 24 (04) : 741 - 748
  • [36] Recreational physical activity and risk of epithelial ovarian cancer
    Rossing, Mary Anne
    Cushing-Haugen, Kara L.
    Wicklund, Kristine G.
    Doherty, Jennifer A.
    Weiss, Noel S.
    CANCER CAUSES & CONTROL, 2010, 21 (04) : 485 - 491
  • [37] Periodontal bone loss and risk of epithelial ovarian cancer
    Ana Babic
    Elizabeth M. Poole
    Kathryn L. Terry
    Daniel W. Cramer
    Ricardo P. Teles
    Shelley S. Tworoger
    Cancer Causes & Control, 2015, 26 : 941 - 947
  • [38] Estrogen replacement therapy and risk of epithelial ovarian cancer
    Risch, HA
    GYNECOLOGIC ONCOLOGY, 1996, 63 (02) : 254 - 257
  • [39] Circulating Inflammation Markers and Risk of Epithelial Ovarian Cancer
    Clendenen, Tess V.
    Lundin, Eva
    Zeleniuch-Jacquotte, Anne
    Koenig, Karen L.
    Berrino, Franco
    Lukanova, Annekatrin
    Lokshin, Anna E.
    Idahl, Annika
    Ohlson, Nina
    Hallmans, Goran
    Krogh, Vittorio
    Sieri, Sabina
    Muti, Paola
    Marrangoni, Adele
    Nolen, Brian M.
    Liu, Mengling
    Shore, Roy E.
    Arslan, Alan A.
    CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION, 2011, 20 (05) : 799 - 810
  • [40] Psychotropic medication use and risk of epithelial ovarian cancer
    Harlow, BL
    Cramer, DW
    Baron, JA
    Titus-Ernstoff, L
    Greenberg, LE
    CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION, 1998, 7 (08) : 697 - 702